ABOUT ENDONOVO

Who We Are

Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical™ Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders.

 

Endonovo's Electroceutical™ Therapy is FDA-Cleared for the palliative treatment of pain and post-surgical edema (swelling) and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Endonovo's Electroceutical™ Therapy has CMS National Coverage for the treatment of chronic wounds. The Company's current pipeline of clinical-stage Electroceutical™ Therapies targets cardiovascular diseases and central nervous system disorders, including ischemic heart disease, acute concussions, post-concussion syndrome, traumatic brain injury (TBI) and multiple sclerosis.

 

Our Vision

Endonovo means to renew from within. Our vision is to develop safe, wearable non-invasive medical devices to deliver our Electroceutical™ Therapy, which harnesses bioelectricity to restore key electrochemical processes that initiate the anti-inflammatory and growth factor cascades necessary for healing to occur.

MEET THE TEAM

Alan Collier – Chairman & Chief Executive Officer

 

Mr. Collier has more than twenty years of experience in corporate finance, IP development, telecommunications and technology with a concentration in healthcare and technology over the last five years. Prior to his appointment as Endonovo’s CEO and chairman, Mr. Collier served as CEO and director of IP Resources International, Inc. where he was instrumental in developing a platform for for the licensing and acquisition of life science and technology companies.

Previously, Mr. Collier served as a Senior Managing Director at Mid-Market Securities, a FINRA-registered Broker-Dealer. Prior to joining Mid-Market Securities, Mr. Collier was a Managing Director at Mosaic capital and co-managed its Capital Markets Group. He was previously a Vice President at Corporate Capital Group and Managing Director and CEO of Greenbridge Capital Group.

Over the progression of his career, he has specialized in the development and financing of early stage, high growth, and acquisitive companies (public and private). He has structured, participated in, and completed numerous transactions including mergers and acquisitions, equity and debt placements, capital restructuring, joint venture development, and channel partner procurement. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Mr. Collier has previously held FINRA Series 7, 79, 63, and 24 Licenses.

Michael Scott Mann – President


Mr. Mann has over 30 years experience in merger and acquisitions and operational management. In 2008 Mr. Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics, Inc,. and led the company to become listed on the OTCBB in 2012.

From January 2003 to April, 2011, Mr. Mann was the Founder, President and Chief Executive Officer of U.S. Debt Settlement, Inc. (USDS), a Frankfurt listed company, where he implemented a growth by acquisition strategy successfully acquiring numerous companies.

From January 2002 to July 2003, Mr. Mann was the Chief Executive Officer of Shared Vision Capital, a boutique investment banking firm that assisted emerging companies with early seed capital and bridge loans. Earlier still, from October 1998 to December 2001, Mr. Mann was the Vice President of Investor Relations for JuriSearch.com, an online legal research platform. During his tenure with JuriSearch.com, Mr. Mann was directly responsible for funding the company’s growth and development. In addition, Mr. Mann founded Universal Pacific Communications, a privately owned telecommunications company. Under his leadership as President, Universal Pacific developed a fiber optic disaster recovery telecommunications network, designed for and successfully marketed to Fortune 1000 companies.

 

Don Calabria – Chief Operating Officer


Mr. Calabria brings over twenty years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance, and business development. Mr. Calabria has a deep level of experience in analyzing companies, determining the operational efficiencies, and conducting operational due diligence on targeted acquisitions.


Previously, Mr. Calabria served as President of Gemini Consulting Group, Inc., a boutique consulting firm which specialized in providing consulting services to companies in multiple marker segments with a core focus directed towards capital structuring and investments, brand strategy and marketing, M&A activities, and operational efficiencies. Prior to this, Mr. Calabria was the VP of Operations for TrinTel Communications; the largest privately held Infrastructure Company in the wireless telecommunications industry. As part of the Company’s initial Senior Management team, which grew the company to a $350+ million valuation in under three years, Mr. Calabria specialized in managing joint venture agreements and strategic alliances as well as directing all subsidiary operations including regional sales, marketing, and business development practices. Prior to this, as the Director of Operations for Wireless Solutions, LLC, he helped facilitate the sale of the company to TrinTel Communications.


Mr. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a BS in Management from Arizona State University.

Steven Barnes – Senior Vice President of Investor Relations


Steven has over 18 years of extensive banking and corporate finance experience representing both the buy and sell side. His corporate, strategic and operational expertise includes public markets, private debt and equity, mergers, acquisitions, divestitures and strategic planning.  He spent 8 years in the securities industry as a licensed (series 7, 63 & 55) representative of a NASD (now FINRA) Beverly Hills/New York based trading firm where he worked as an institutional trader, financial analyst and money manager. In 2003 Steven founded and was the principal of Empire Financial, Inc., a full service investment banking and corporate advisory firm in Los Angeles, California.  He structured numerous private and public debt and equity offerings in many diverse sectors including biotechnology, healthcare, entertainment, and hardware/software technology companies.

Contact Us:  info@sofpulse.com

Copyright 2018-2019 Endonovo Therapeutics, Inc.
All Rights Reserved | www.endonovo.com

Endonovo_Logo_red_opt.png
  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon

The information included in this web site has been prepared for and is intended for viewing by residents of the United States of America. This web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us regarding the purchase or sale of SofPulse in other countries.